The following sections summarize the available evidence about lactoferrin’s therapeutic effectiveness toward different diseases, such as gastroenteric diseases, neonatal sepsis, and necrotizing enterocolitis, lung diseases, and COVID-19. This evidence concerns the gene LTF and COVID-19.